2 Mooning Stocks on Our Buy List and 1 That Underwhelm
3 Market-Beating Stocks Worth Your Attention
Amid the biotechnology sector's transformative era the Direxion Daily Biotech Top 5 Bull 2X ETF ($TBXU) offers traders a new, single-trade solution to gain 2X daily leveraged exposure to an e
3 Reasons Investors Love United Therapeutics (UTHR)
The 5 Most Interesting Analyst Questions From United Therapeutics’s Q3 Earnings Call
United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that company executives will provide an overview and update on the company during fireside...
The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives
Ongoing EXPAND Study is the First Clinical Trial to Evaluate Xenotransplantation in End-Stage Renal Disease
2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid
UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook